Cargando…

DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer

Detalles Bibliográficos
Autor principal:	Tost, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563144/ https://www.ncbi.nlm.nih.gov/pubmed/26425682 http://dx.doi.org/10.1016/j.ebiom.2015.08.015

Ejemplares similares

Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017)

New approaches for detecting cancer with circulating cell-free DNA
por: Fiala, Clare, et al.
Publicado: (2019)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

CLOCK’ing differences in DNA methylation signatures to understand the molecular etiology of lung cancer
por: Neely, Aaron M., et al.
Publicado: (2023)

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
por: Kim, Si-Cho, et al.
Publicado: (2023)

ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack
por: Mooradian, Meghan J., et al.
Publicado: (2017)

Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
por: Brenner Thomsen, Caroline, et al.
Publicado: (2022)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

The struggle to detect circulating DNA
por: Zeerleder, Sacha
Publicado: (2006)

Clinical applications of DNA methylation profiling in lung cancer
por: Castro-Gonzalez, Sergio, et al.
Publicado: (2023)

Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection
por: Bahado-Singh, Ray, et al.
Publicado: (2022)

Diagnostic potential of circulating cell-free DNA in patients needing mechanical ventilation: promises and challenges
por: Arnalich, Francisco, et al.
Publicado: (2011)

Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
por: García-Ortiz, María Victoria, et al.
Publicado: (2023)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Origin of circulating free DNA in patients with lung cancer
por: Abe, Tomonori, et al.
Publicado: (2020)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
por: Salta, Sofia, et al.
Publicado: (2018)

A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer
por: Shinjo, Keiko, et al.
Publicado: (2020)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Cell-free DNA and outcome in sepsis
por: Rhodes, Andrew, et al.
Publicado: (2012)

DNA methylation dynamics during pregnancy
por: Fradin, Delphine, et al.
Publicado: (2023)

Applying circulating tumor DNA methylation in the diagnosis of lung cancer
por: Li, Lei, et al.
Publicado: (2019)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
por: Chen, Kezhong, et al.
Publicado: (2023)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

DNA methylation profiling in early lung adenocarcinoma to predict response to immunotherapy
por: De Smet, Charles
Publicado: (2023)

DNA methylation in cancer: From mouse to human and back again
por: Esteller, Manel
Publicado: (2021)

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
por: Chiappinelli, Katherine B., et al.
Publicado: (2022)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021)

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
por: Li, Wenshuai, et al.
Publicado: (2017)

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
por: Mack, Elisabeth K. M., et al.
Publicado: (2022)

Simultaneous Discovery of Cell-Free DNA and the Nucleosome Ladder
por: Henikoff, Steven, et al.
Publicado: (2018)

DNA Methylation and Chromatin: Role(s) of Methyl-CpG-Binding Protein ZBTB38
por: de Dieuleveult, Maud, et al.
Publicado: (2018)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Early Warning Biomarkers for COVID-19 Progression and Myocardial Injury
por: Chen, Hang-yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oa2tlsnohghq87q04jifo45pgl